iVascular
Aymeric Pont is currently serving as the Finance & Controlling Manager at iVascular since September 2022. Previously, Aymeric worked as a Financial Auditor at KPMG GLD et Associés Monaco from September 2020 to August 2022 and was a Corporate Development M&A Analyst at AUDIKA for a brief period in 2019. Prior experience also includes a role in Financial & Budget Management at Amadeus in early 2019 and a summer position as a Cabin Crew Member at Air France in 2017. Aymeric holds a Master's degree in Global Business Management from North Carolina State University, a Programme Grande Ecole degree in Corporate Finance from SKEMA Business School, and a Bachelor's degree in Economics & Management from Université Côte d'Azur. Education began with a Baccalauréat in Science from Lycée du Parc Impérial.
This person is not in any offices
iVascular
1 followers
The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global